F.D.A. Says No, for Now, to an Amgen Bone Drug
Monday, October 19, 2009 - 17:14
in Health & Medicine
The agency declined to approve a medication called denosumab, meant to treat osteoporosis, until it has more data.
Updated by artificial intelligence Tue, 13 Jun 2023, 2:53:47 UTC Learn more
- Tell your friends
- Get science news via